financetom
Business
financetom
/
Business
/
Bridger Aerospace Soars 20% After Q3 Beat: CEO Praises 'Strong Performance' Of Super Scoopers, Air Attack Aircraft
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bridger Aerospace Soars 20% After Q3 Beat: CEO Praises 'Strong Performance' Of Super Scoopers, Air Attack Aircraft
Nov 12, 2024 7:15 PM

Bridger Aerospace Group Holdings, Inc. ( BAER ) shares are trading higher after the company reported third-quarter 2024 results on Monday.

Revenue grew around 20% to $64.5 million, exceeding the consensus of $57.5 million.

Revenue growth was led by higher flight revenue, along with approximately $2.2 million from return-to-service work on the four Spanish Super Scoopers under the partnership with MAB Funding LLC, and around $1.6 million from the June acquisition of FMS.

Adjusted EBITDA stood at $47 million vs. $38.7 million a year ago quarter. EPS of $0.31 missed the consensus of 46 cents.

As of Sept. 30, 2024, cash, cash equivalents and restricted cash stood at $42.6 million.

Sam Davis, Bridger’s CEO, said, “This strong performance of our six Super Scoopers and six Air Attack aircraft during the 2024 wildfire season validates our business model and, with some of our aircraft still deployed, positions us for a record year, including an approximate doubling of Adjusted EBITDA from 2023 and the generation of positive free cash flow after maintenance capital expenditures and debt service.”  

Outlook: Bridger Aerospace ( BAER ) raised FY24 sales guidance from $70 million to $86 million to $95 million (vs. estimate of $82.8 million).

The company expects its 2024 adjusted EBITDA to increase by over 85%, reaching a range of $35 million to $40 million, compared to the initial guidance range of $35 million to $51 million.

Bridger Aerospace ( BAER ) expects to generate positive free cash flow in 2024.

Price Action: Bridger shares are up 20% at $4.20 premarket at the last check Tuesday.

Read Next:

EXCLUSIVE: Pineapple Adds Luxe Lending And Mortgage Magic, Eyes Strong Revenue Growth

Image:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Heritage Commerce Appoints New Chief Operating Officer
Heritage Commerce Appoints New Chief Operating Officer
Oct 2, 2024
04:58 PM EDT, 10/02/2024 (MT Newswires) -- Heritage Commerce ( HTBK ) said Wednesday it has appointed Thomas Sa as chief operating officer of the company and its unit Heritage Bank of Commerce. Sa previously served as president, chief operating officer and chief financial officer of California BanCorp and its subsidiary, California Bank of Commerce, according to Heritage Commerce (...
US FAA ends enhanced oversight of United Airlines after safety review
US FAA ends enhanced oversight of United Airlines after safety review
Oct 2, 2024
WASHINGTON, Oct 2 (Reuters) - The Federal Aviation Administration said Wednesday it has completed a review of United Airlines and ended its enhanced oversight and approval process for the Chicago-based carrier to add aircraft and services. The review did not identify any significant safety issues, the FAA said in a statement. The FAA in March opened a review to ensure...
Paladin's $846M Fission Uranium Deal Draws Scrutiny As Canadian Regulators Flag Foreign Investments
Paladin's $846M Fission Uranium Deal Draws Scrutiny As Canadian Regulators Flag Foreign Investments
Oct 2, 2024
Canadian regulators put Paladin Energy‘s (OTC:PALAD) acquisition of Fission Uranium ( FCUUF ) under review, citing national security concerns. What Happened: Paladin Energy agreed in June to acquire Fission Uranium ( FCUUF ) for CAD 1.14 billion ($846 million). The Subiaco, Australia-based miner looked to capitalize on rising uranium prices by consolidating assets. However, Canada's Minister of Innovation, Science and...
Spero Therapeutics Phase 1 Trial of Lung Disease Treatment Backs Further Assessment
Spero Therapeutics Phase 1 Trial of Lung Disease Treatment Backs Further Assessment
Oct 2, 2024
04:58 PM EDT, 10/02/2024 (MT Newswires) -- Spero Therapeutics ( SPRO ) said Wednesday that results from a phase 1 trial evaluating the safety and intrapulmonary pharmacokinetics of SPR719 back its further investigation to treat non tuberculous mycobacterial-pulmonary disease, or NTM-PD. Effective oral therapy for NTM lung disease requires adequate uptake into the pulmonary epithelial lining fluid and alveolar macrophages,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved